<DOC>
	<DOCNO>NCT00795483</DOCNO>
	<brief_summary>The purpose project determine incidence osteoporosis investigator ' population HIV-infected patient assess efficacy security zoledronic acid , whose efficacy post-menopausal woman high fracture risk treatment Paget 's disease treatment already demonstrate .</brief_summary>
	<brief_title>Efficacy And Security Of Annual And Biennial Zoledronic Acid For Osteoporosis Treatment In An HIV-Infected Patients ' Cohort</brief_title>
	<detailed_description>The low bone mineral density describe patient HIV-infection meant increase long term complication . Nevertheless , could involve increase associate co-morbidity future , take care general population osteoporosis increase 4 time pathologic fracture risk . That necessary know real prevalence osteoporosis population patient real dimension problem define . This project will determine incidence osteoporosis population HIV-infected patient assess efficacy security zoledronic acid . If annual use endovenous zoledronic acid obtains equivalent result obtain oral weekly alendronate study population , use would justify posology benefit . The annual administration improve compliance patient receive big quantity drug , HIV-infected patient , probably treat life . Moreover , elimination renal absence interaction antiretroviral drug make zoledronic acid promise alternative . Finally , risk digestive intolerance parenteral administration well posology oral bisphosphonates .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Zoledronic acid</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<criteria>1 . 18 year old old . 2 . Documented HIV1 infection , without antiretroviral treatment . 3 . Presence WHO osteoporosis criterion , define tscore 2.5 lumbar , hip and/or trochanter ( DEXA last 6 month need ) . 4 . Willing follow study protocol . 5 . Informed Consent signature . 1 . In woman , pregnancy breastfeeding . 2 . Other possible cause secondary osteoporosis . 3 . Creatinine 2.3 mg/mL . 4 . Glomerular filter le 50 mL/min ( estimate MDRD ) . 5 . Treatment Osteoporosis last 4 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Osteoporosis</keyword>
	<keyword>HIV infection</keyword>
	<keyword>Bisphosphonates</keyword>
	<keyword>Zoledronic acid</keyword>
</DOC>